RVL Pharmaceuticals plc — Net Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d640b87e-881b-4ff7-9b02-644d3001b48c/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-51.7M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-004211 |
| FY 2021 | $-64.9M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-004770 |
| FY 2020 | $-79.6M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-011836 |
| FY 2019 | $-270.9M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-002906 |
| FY 2018 | $-109.7M | 2018-01-01 – 2018-12-31 | evidence 0001558370-20-002906 |
| FY 2017 | $-41.3M | 2017-01-01 – 2017-12-31 | evidence 0001558370-19-011660 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
RVL Pharmaceuticals plc — all facts · Revenue · Operating Income